Search
Patient organizations
EHA greatly values the collaboration with patient organizations in a growing number of areas, from joint advocacy and a strong presence at the EHA Annual Congress – with a prominent place for the EHA-Patient Joint Symposium on policy and regulatory…
Read moreHemaSphere Editorial Board
Editor-in-Chief
Jan Cools, Belgium
Deputy Editor-in-Chief
Claire Harrison, United Kingdom
Associate Editors
Jeroen Eikenboom, The Netherlands
Simone Ferrero (Italy)
Adele Fielding, United Kingdom
Simon Hallam, United Kingdom
Robert Hills, United Kingdom
Steffen Koschmieder, Germany
Marek Mraz (Czech Republic)
Paula Rodríguez Otero, Spain
Juerg Schwaller, Switzerland
Francesca Vinchi, USA
Scientific Editors
Charles de Bock, Australia
Stephen Hibbs, United…
EHA Exam
An annual assessment designed to test your knowledge of the European Hematology Curriculum. EHA Exam 2025
The 9th European Hematology Exam will take place on June 12, 2025, from 13:30–16:00 (CEST).
Young EHA Committee call for interest
The mission of the Young EHA Committee is to:
Represent the voice of young and early career hematologists and scientists within EHA
Engage these junior members in EHA and EHA-related events
Foster the Young EHA community within the field of hematology
This year, we…
Research Committee call for interest
The overarching aim of the Research Committee is to further strengthen EHA’s interactions with and relevance for the wider hematological research community.
Read moreParticipation grants & abstract awards
Participation grants
The call for participation grant applications has closed on March 1, 2021 (23:59 CET). Participation grant application has closed
Participation Grants (previously called Travel Grants) provide complimentary registration for the upcoming EHA Virtual Congress.
Immunoglobulin shortages in the spotlight: EMA, SUPPLY and the SoHO Regulation
EMA executive director Emer Cooke welcoming participants including EHA at the Shortages Workshop, March 1
Shortages of immunoglobulins and the need to increase and sustain plasma supplies have moved to the center of the EU policy and regulatory stage.